> Home > Newsroom

Champalimaud Cancer Talks: "Progress Toward Conquering Breast Cancer" - November 4th at 7 pm - Register now

Professor Larry Norton, renowned breast oncologist leader in the development of drug treatments for breast cancer, will open the new session of The Champalimaud Cancer Talks with a public lecture, at 7 pm on November 4th, at the Champalimaud Centre for the Unknown.

  1. 9.10.2015

    On November 4th at 7 pm the Champalimaud Foundation will receive Professor Larry Norton, for a public lecture on "Progress Toward Conquering Breast Cancer". This event – which takes place as part of the “Champalimaud Cancer Talks” series – is organised by the Champalimaud Foundation with the objective of offering the general public a unique opportunity to hear one of the leading global authorities on breast cancer talk about this disease. 

    Professor Larry Norton is well known for his work focusing on the use of medicines to treat cancer, particularly the application of mathematical methods to optimizing dose and schedule. He has been involved in the development of several effective agents including paclitaxel and trastuzumab. He co-invented the Norton-Simon Model of cancer growth, which has broadly influenced cancer therapy, and more recently the self-seeding concept of cancer metastasis and growth.

    Registration

    Entrance is free and, due to the limited number of available places, participants are kindly invited to register their participation online  here. On the day of the event if there are vacant seats available, they will be appointed on a first come first served basis. If you already registered, please don't forget to bring your e-ticket, either printed or on you mobile device. We look forward to seeing you at the Champalimaud Centre for the unknown. 

    About the speaker:

    Dr. Larry Norton is currently the Deputy Physician in Chief, Memorial Hospital, Memorial Sloan-Kettering Cancer Center, New York, for Breast Cancer Programs, and The Medical Director of MSKCC’s Breast and Imaging Center, which contains the Evelyn H. Lauder Breast Center. He is the founding incumbent of the Norna S. Sarofim Chair of Clinical Oncology at MSKCC and a Professor of Medicine in the Weill Medical College of Cornell University. He received his AB with Highest Distinction from the University of Rochester and his MD from the College of Physicians and Surgeons of Columbia University. He trained in medicine and medical research at the Albert Einstein College of Medicine and the National Cancer Institute.

    Dr. Norton has dedicated his life to the eradication of cancer by activities in medical care, laboratory and clinical research, advocacy, and government. He was a U.S. Presidential appointee to the National Cancer Advisory Board—the board of directors of the NCI—serving as Chair of the Budget Sub-Committee. A former Director of the American Society of Clinical Oncology, he served as President of ASCO and subsequently Chair of the ASCO Foundation. He has been Vice-Chair of the Lymphoma Committee and a long-serving Chair of the Breast Committee of the Cancer and Leukemia Group B. Dr. Norton is a founder of The Breast Cancer Research Foundation and is currently its Scientific Director. He has served on or chaired numerous committees of the National Cancer Institute, National Institutes of Health, and the Institute of Medicine of the National Academy of Sciences. He is an editorial board member or reviewer for numerous medical journals and on the advisory boards of many advocacy and medical institutions including the Cold Spring Harbor Laboratory Cancer Center and several Specialized Programs of Research Excellence.

    Dr. Norton’s personal research has focused on the use of medicines to treat cancer, particularly the application of mathematical methods to optimizing dose and schedule. He has been involved in the development of several effective agents including paclitaxel and trastuzumab. He co-invented the Norton-Simon Model of cancer growth, which has broadly influenced cancer therapy, and more recently the self-seeding concept of cancer metastasis and growth. He is the Principal Investigator of an NCI Program Project Grant in Models of Human Breast Cancer and an author of more than 350 published articles and many book chapters.

    For his work Dr. Norton has received many honors including election to Phi Beta Kappa and Alpha Omega Alpha and recognition from the M.D. Anderson Cancer Center, the Society for MSKCC, the Italian-American Foundation for Cancer Research, the Don Shula Foundation, SHARE (NY), the Susan G. Komen Foundation, and The Breast Cancer Research Foundation. He received ASCO’s highest honor, the David A. Karnofsky Award, and was a McGuire Lecturer at the San Antonio Breast Cancer Symposium, the Willet F. Whitmore Award for Clinical Excellence and the Gianni Bonadonna Breast Cancer Award. Most recently, he has received Columbia University, Physicians and Surgeons Alumni Association’s Gold Medal for Outstanding Achievement in medical research. He has served as a visiting professor throughout the U.S., Canada, South America, Europe, Israel, and Asia and has trained many cancer physicians and researchers.




  1. Go back

 

RSS feed

Keep up to date with the latest news on the Champalimaud Foundation by subscribing our RSS feed. RSS feed